Cardinal Financial About To Put More Money In Your Pocket (CFNL)

Looking at the universe of stocks we cover at Dividend Channel, on 5/5/15, Cardinal Financial Corp (CFNL) will trade ex-dividend, for its quarterly dividend of $0.11, payable on 5/22/15. As a percentage of CFNL's recent stock price of $20.81, this dividend works out to approximately 0.53%, so look for shares of Cardinal Financial Corp to trade 0.53% lower — all else being equal — when CFNL shares open for trading on 5/5/15.

START SLIDESHOW:
Click here to learn which 25 S.A.F.E. dividend stocks should be on your radar screen »

Below is a dividend history chart for CFNL, showing historical dividends prior to the most recent $0.11 declared by Cardinal Financial Corp:

CFNL+Dividend+History+Chart

In general, dividends are not always predictable; but looking at the history above can help in judging whether the most recent dividend from CFNL is likely to continue, and whether the current estimated yield of 2.11% on annualized basis is a reasonable expectation of annual yield going forward.The chart below shows the one year performance of CFNL shares, versus its 200 day moving average:

Cardinal Financial Corp 200 Day Moving Average Chart

Looking at the chart above, CFNL's low point in its 52 week range is $15.93 per share, with $21.20 as the 52 week high point — that compares with a last trade of $20.81.

In Friday trading, Cardinal Financial Corp shares are currently up about 0.9% on the day.

More from Stocks

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

3 Great Stock Market Sectors Millennials Should Invest In

3 Great Stock Market Sectors Millennials Should Invest In

Why Millennials Are Ditching Stocks for ETFs

Why Millennials Are Ditching Stocks for ETFs

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says